# A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency

> **NCT00308464** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 136 (—)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** PHA-794428

## Key facts

- **NCT ID:** NCT00308464
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 136 (—)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2011-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308464, "A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00308464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*